[go: up one dir, main page]

MX2010006253A - Proceso para la preparación de 5-(2-etil-dihidro-1h-inden-2-il)-1h -midazol y sales de los mismos. - Google Patents

Proceso para la preparación de 5-(2-etil-dihidro-1h-inden-2-il)-1h -midazol y sales de los mismos.

Info

Publication number
MX2010006253A
MX2010006253A MX2010006253A MX2010006253A MX2010006253A MX 2010006253 A MX2010006253 A MX 2010006253A MX 2010006253 A MX2010006253 A MX 2010006253A MX 2010006253 A MX2010006253 A MX 2010006253A MX 2010006253 A MX2010006253 A MX 2010006253A
Authority
MX
Mexico
Prior art keywords
salts
inden
dihydro
imidazole
ethyl
Prior art date
Application number
MX2010006253A
Other languages
English (en)
Inventor
Inese Reine
Armands Zandersons
Viesturs Lusis
Dzintra Muceniece
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of MX2010006253A publication Critical patent/MX2010006253A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

La presente invención se refiere a un método altamente eficiente para preparar 5-(2-etil-2,3-dihidro-1H-inden-2-il)-1H-imidazol y sus sales, en particular sus sales farmacéuticamente aceptables.
MX2010006253A 2007-12-05 2008-12-03 Proceso para la preparación de 5-(2-etil-dihidro-1h-inden-2-il)-1h -midazol y sales de los mismos. MX2010006253A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122400 2007-12-05
PCT/EP2008/066709 WO2009071584A1 (en) 2007-12-05 2008-12-03 Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof

Publications (1)

Publication Number Publication Date
MX2010006253A true MX2010006253A (es) 2010-08-18

Family

ID=39092917

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006253A MX2010006253A (es) 2007-12-05 2008-12-03 Proceso para la preparación de 5-(2-etil-dihidro-1h-inden-2-il)-1h -midazol y sales de los mismos.

Country Status (15)

Country Link
US (1) US8431717B2 (es)
EP (1) EP2225209B1 (es)
JP (1) JP2011506284A (es)
KR (1) KR20100086029A (es)
CN (1) CN101889003A (es)
AR (1) AR069759A1 (es)
AT (1) ATE551327T1 (es)
AU (1) AU2008333261A1 (es)
BR (1) BRPI0819056A2 (es)
CA (1) CA2706340C (es)
CL (1) CL2008003553A1 (es)
EA (1) EA016832B1 (es)
MX (1) MX2010006253A (es)
NZ (1) NZ586521A (es)
WO (1) WO2009071584A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108403692B (zh) * 2018-03-26 2019-08-16 中国人民解放军军事科学院军事医学研究院 盐酸阿替美唑作为非特异性p450酶抑制剂的应用
CN112225700B (zh) * 2020-11-12 2023-11-17 湖南新合新生物医药有限公司 一种阿替美唑的制备方法
LU103072B1 (en) 2023-02-15 2024-08-19 Univ Ljubljani N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-lH-IMIDAZOLE-l-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
EP4658639A1 (en) 2023-02-01 2025-12-10 Univerza V Ljubljani N,n-dialkyl-4-(2-ethylindan-2-yl)-1h-imidazole-1-carboxamides and related compounds for treatment of neurodegenerative diseases
CN117186010A (zh) * 2023-08-15 2023-12-08 厦门欧瑞捷生物科技有限公司 一种盐酸阿替美唑的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3872095A (en) * 1967-09-15 1975-03-18 Bayer Ag N-trityl-imidazoles and their production
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
GB9425211D0 (en) * 1994-12-14 1995-02-15 Ucb Sa Substituted 1H-imidazoles
FI116292B (fi) * 2003-01-08 2005-10-31 Juvantia Pharma Ltd Oy Menetelmä substituoitujen imidatsolijohdannaisten valmistamiseksi ja menetelmässä käytettäviä välituotteita
EP1633724B1 (en) * 2003-03-12 2011-05-04 Kudos Pharmaceuticals Limited Phthalazinone derivatives
FI20050657A0 (fi) * 2005-06-17 2005-06-17 Orion Corp Atipametsolin kiteytysmenetelmä

Also Published As

Publication number Publication date
EP2225209A1 (en) 2010-09-08
CA2706340C (en) 2016-04-05
US8431717B2 (en) 2013-04-30
EA201000740A1 (ru) 2010-12-30
KR20100086029A (ko) 2010-07-29
JP2011506284A (ja) 2011-03-03
NZ586521A (en) 2012-02-24
BRPI0819056A2 (pt) 2015-05-05
US20110028733A1 (en) 2011-02-03
AU2008333261A1 (en) 2009-06-11
CA2706340A1 (en) 2009-06-11
ATE551327T1 (de) 2012-04-15
EP2225209B1 (en) 2012-03-28
AR069759A1 (es) 2010-02-17
EA016832B1 (ru) 2012-07-30
WO2009071584A1 (en) 2009-06-11
CL2008003553A1 (es) 2009-11-27
CN101889003A (zh) 2010-11-17

Similar Documents

Publication Publication Date Title
WO2008100384A3 (en) Activin-actriia antagonists and uses for promoting bone growth in cancer patients
WO2009107121A8 (en) Medical apparatus and method for attaching a suture to a bone
MX2009007337A (es) Indazoles sustituidos con 5-piridinona.
WO2011028044A3 (ko) 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
WO2011028043A3 (ko) 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물
WO2007103666A3 (en) Implantable medical endoprosthesis delivery systems
WO2008091835A3 (en) Implantable medical endoprostheses
PH12013500870A1 (en) Heterocyclic compounds and uses thereof
TN2010000071A1 (en) Fused imidazoles or cancer treatment
SG166805A1 (en) Adhesive formulation, method for the production thereof, and use thereof
WO2007117692A3 (en) Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
GEP20125647B (en) Kinesin inhibitors as cancer therapeutics
PL2401263T3 (pl) Podstawione pochodne azotu, zawierająca pochodne kompozycja farmaceutyczna, i sposób leczenia choroby Parkinsona przy ich użyciu
WO2008055852A8 (en) Method for preparing medetomidine and its salts
ZA200904175B (en) Imidazole derivatives as kinesin spindle protein inhibitors (EG-5)
MY159244A (en) Method of reducing intraocular pressure in humans
MX2010006253A (es) Proceso para la preparación de 5-(2-etil-dihidro-1h-inden-2-il)-1h -midazol y sales de los mismos.
MX2011008280A (es) Derivados de cilopropilamida hacia receptor de histamina h3.
MX2010002667A (es) Cianoaminoquinolonas y tetrazoloaminoquinolonas como inhibidores de gsk-3.
WO2009130604A3 (en) Solid state forms of deferasirox salts and process for the preparation thereof
CY1125333T1 (el) Μεθοδος παρασκευης μιας κρυσταλλικης μορφης της μηλεϊνικης 1-((2r, 4r)-2- (1h-benzo[d] ιμιδαζολ-2- υλο)-1-μεθυλο-πιπεριδιν-4-υλο)-3-(4- κυανοφαινυλ)ουριας· μια κρυσταλλικη μορφη συμπλοκου 1-((2r, 4r)-2- (1h-benzo[d] ιμιδαζολ-2- υλο)-1-μεθυλοπιπεριδιν-4-υλο)-3-(4-κυανοφαινυλ) ουριας ιμιδαζολης (1:1)
WO2011005052A8 (en) Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
WO2009146099A3 (en) Contrast agents, methods for preparing contrast agents, and methods of imaging
IN2012DN03844A (es)
TN2009000068A1 (en) Salts of benzimidazolyl pyridyl ethers and formulations thereof

Legal Events

Date Code Title Description
FG Grant or registration